ArticleJournal of thoracic disease2019

PD1/PD-L1 inhibitor treatment for late stage non-small cell lung carcinoma, sometimes…does more harm than good!

Paul HofmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.